yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26795781-3F8D3C4F-22F0-4206-BBFE-F50710DC2FB4
Q26795781-3F8D3C4F-22F0-4206-BBFE-F50710DC2FB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26795781-3F8D3C4F-22F0-4206-BBFE-F50710DC2FB4
Targeting the Checkpoint to Kill Cancer Cells
P2860
Q26795781-3F8D3C4F-22F0-4206-BBFE-F50710DC2FB4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26795781-3F8D3C4F-22F0-4206-BBFE-F50710DC2FB4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8295315307012dc948fc2d4bc26ed8c9530fc9b
P2860
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.